George M. Milne Jr.
Director · Amylyx Pharmaceuticals, Inc.
IndividualSelling only1 10b5-1 trade
- 2025
- Oct 7, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies George M. Milne Jr. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Joshua B. Cohen - $3.60M in AMLX purchases and sales in the last 12 months
- Justin B. Klee - $3.59M in AMLX purchases and sales in the last 12 months
- Gina Mazzariello - $1.05M in AMLX purchases and sales in the last 12 months
- James M. Frates - $554K in AMLX purchases and sales in the last 12 months
- Camille L. Bedrosian - $513K in AMLX purchases and sales in the last 12 months
- Karen Firestone - $152K in AMLX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is George M. Milne Jr.?
George M. Milne Jr. is a corporate insider, tracked as Director of Amylyx Pharmaceuticals, Inc. (AMLX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has George M. Milne Jr. submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has George M. Milne Jr. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($831K) across all tracked filings.
